Mekophar records first loss as major pharma firms post Q2 profits
Ho Chi Minh City-based Mekophar posted its first loss in the second quarter, while most other pharma industry majors in Vietnam reported significant profit growth.
Mekophar (MKP) reported a loss of VND104.5 billion ($4.4 million) in Q2, the first loss in its history. It earned net revenues of VND207 billion ($8.7 million), up 10% year-on-year, according to its financial statement.
The company attributed the loss to a decrease in market demand, impacts of competition from other businesses, and problems with registration numbers.
In the first six months of 2023, Mekophar posted net revenues and after-tax profits of VND443 billion ($18.7 million) and VND4.3 billion ($181,600), down 28% and 81%, respectively.
As of June 30, Mekophar's total assets were valued at VND1.54 trillion ($65.2 million), down 5% compared to the beginning of the year, with cash and cash equivalents at VND36.7 billion ($1.55 million), down 40%.
For 2023, the firm has targeted revenues and pre-tax profits of VND1.1 trillion ($46.5 million) and VND50 billion ($2.11 million), respectively.
On the Unlisted Public Company Market (UpCOM), MKP shares closed Tuesday’s session at VND26,600 ($1.12).
The firm attributed the loss to low demand and stiff competition, among other problems.

A testing lab run by Hau Giang Pharmaceutical JSC. Photo courtesy of the company.
In stark contrast, Hau Giang Pharmaceutical JSC (DHG Pharma) reported an after-tax profit of VND263 billion ($11.1 million) in Q2, up 12% year-on-year.
The company, listed on the Ho Chi Minh Stock Exchange (HoSE) as DHG, posted a net revenue of nearly VND1.15 trillion ($48.7 million), up 3%, according to its financial statement.
Hau Giang Pharmaceutical said continued focus on trading strategic and key products, better organization of its distribution system as well as its connection with customers have helped its positive performance.
In the first six months of this year, DHG posted net revenues of VND2.38 trillion ($100.57 million) and after-tax profits of over VND624 billion ($26.4 million), up 9% and 27% year-on-year, respectively.
As of June 30, 2023, DHG's total assets value increased by 10.8% compared to the beginning of the year to VND5.73 trillion ($241.8 million). Of this, cash deposits of VND2.32 trillion ($98 million) and inventories worth VND1.49 trillion ($62.9 million) were down 1.5% and 19.1%, respectively.
For 2023, DHG Pharma has set revenue and pre-tax profit targets of VND5 trillion ($212.8 million) and VND1.13 trillion ($48.1 million), up 7% and 3% respectively.
At the close of Wednesday’s session, DHG was trading at VND124,400 ($5.25) per share.
Meanwhile, Imexpharm Corporation (IMP) posted net revenues and after-tax profits of nearly VND440 billion ($18.5 million) and VND79.7 billion ($3.4 million) in Q2, up 24% and 71% year-on-year, respectively.
Imexpharm recorded H1 net revenue and after-tax profits of VND919 billion ($38.8 million) and VND157.5 billion ($6.6 million), up 37% and 58%, respectively.
At the end of June, IMP's total assets stood at nearly VND2.52 trillion ($106.6 million), up 11% compared to the beginning of the year, with cash and cash equivalents at VND66.8 billion ($2.8 million), down 62%.
For 2023, IMP has set net revenue and pre-tax profit targets of VND1.62 trillion ($68.4 million) and VND305 billion ($12.88 million), respectively.
On the Ho Chi Minh Stock Exchange (HoSE), the IMP share price traded for VND72,500 ($3.06) at Wednesday's closing session.
Top broker SSI Securities said that while the post-pandemic situation will remain stable in most aspects, an economic downturn could stall spending on healthcare.
The first half of 2024 will be an unpredictable time for the supply of active pharmaceutical ingredients (API) and excipients. About 65% of API used in the production of drugs in Vietnam is imported from China, which has reopened, but SSI Securities predicted that shortages could still occur.
In addition, the Russia-Ukraine conflict continued and there was a risk of shortage of API and drugs imported from Europe. Companies that can use domestic raw materials will gain a better position, the broker said.
SSI expects pharma industry revenue to reach VND169 trillion ($7.2 billion) in 2023, up 8% year-on-year.
Meanwhile, Agribank Securities (Agriseco) assessed pharmaceutical industry profits would remain stable in 2023. The pharmaceutical industry is known to be a defensive one in the context of the economy facing many difficulties. Besides, Vietnam’s pharmaceutical industry still has a lot of potential for development in the medium and long term as the country’s population size is large and aging at a rapid rate. The increase in per capita income also helps people to spend more on medical and healthcare products, Agriseco noted.
- Read More
Vietnamese fruit and vegetable export to EU grows 33% in 4 months
Vietnamese fruits and vegetables such as mangoes, pistachios, pineapples, and coconuts are gaining popularity in the European market, with export revenues rising sharply in Jan-April by as much as 41% to 200% year-on-year.
Economy - Mon, June 16, 2025 | 4:19 pm GMT+7
Vietnam's oil shipping major PVTrans to pay record high dividend
PetroVietnam Transportation Corporation (PVTrans), a subsidiary of state-owned Petrovietnam, will issue nearly 113.9 million shares to pay 2024 dividends, raising its charter capital to VND4,699 billion (over $180 million).
Companies - Mon, June 16, 2025 | 3:51 pm GMT+7
How retail giant Aeon Mall rapidly expands presence in Vietnam
Japanese retailer Aeon Mall has employed a consistent strategy to expand its footprint across Vietnam: partnering with domestic companies that possess land funds earmarked for commercial real estate development.
Real Estate - Mon, June 16, 2025 | 12:10 pm GMT+7
Two Vietnamese stocks face bourse delisting for information disclosure violations
Nam Song Hau Trading and Investing Petroleum JSC (PSH) and Koji Asset Investment JSC (KPF) are facing mandatory delisting from the Ho Chi Minh Stock Exchange (HoSE) due to serious breaches of information disclosure regulations.
Finance - Mon, June 16, 2025 | 9:20 am GMT+7
MBBank offers free app for business households' sales management, electronic invoice issuance
MBBank (MB) is offering its mSeller application for free – a solution to support sales management and issuance of electronic invoices exclusively for business households, small traders, and micro-sized enterprises.
Companies - Mon, June 16, 2025 | 9:05 am GMT+7
How to invest in a volatile Vietnamese stock market
After a strong recovery from the market bottom of 2025 on April 9, the VN-Index has entered a correction phase, with six out of eight sessions showing declines between June 4 and Friday, June 13.
Finance - Mon, June 16, 2025 | 8:00 am GMT+7
Third round of Vietnam-US reciprocal trade pact talks sees 'significant progress'
The third technical round of negotiations for a reciprocal trade agreement between Vietnam and the U.S. has concluded in Washington, D.C., with "significant progress made and gaps narrowed in all areas of negotiation," according to Vietnam’s Ministry of Industry and Trade.
Economy - Sun, June 15, 2025 | 9:57 pm GMT+7
HCMC seeks to expand infrastructure cooperation with Guangdong-Hong Kong-Macao Greater Bay Area
Ho Chi Minh City is aiming to expand cooperation with the Guangdong-Hong Kong-Macao Greater Bay Area (China) in infrastructure, one of the city’s key sectors following its merger with Binh Duong and Ba Ria-Vung Tau provinces.
Economy - Sun, June 15, 2025 | 8:00 pm GMT+7
Digital assets legalized in Vietnam
Vietnam has officially legalized digital assets with the approval of the Law on Digital Technology Industry by the National Assembly, the country's legislature, on Saturday.
Finance - Sun, June 15, 2025 | 3:07 pm GMT+7
$2.5 bln LNG power plant in northern Vietnam set for groundbreaking in late 2025
A $2.56 billion LNG-fueled power project in the northern Vietnam province of Thai Binh is slated to break ground later this year, according a project report dated June 2025.
Energy - Sun, June 15, 2025 | 10:06 am GMT+7
Vietnam’s tech unicorn VNG expects 2025 loss to narrow by 47%, plans name change
VNG Corporation, Vietnam’s first tech unicorn, projects a net loss of VND620 billion ($2.38 million) in 2025, down 47% from last year.
Companies - Sun, June 15, 2025 | 8:00 am GMT+7
Prime Minister suggests AstraZeneca build pharma factory in Vietnam
Vietnam is willing to license AstraZeneca immediately to build vaccine and pharmaceutical factories, said Prime Minister Pham Minh Chinh.
Industries - Sat, June 14, 2025 | 10:59 pm GMT+7
Sugary drinks subject to excise tax in Vietnam from 2027
Sugary drinks in Vietnam will be subject to an 8% excise tax starting in early 2027 and 10% from 2028, according to the adjusted Excise Tax Law, passed by the parliament on Saturday.
Economy - Sat, June 14, 2025 | 4:56 pm GMT+7
Ericsson should focus on 6G research, build database for AI in Vietnam: Prime Minister
Prime Minister Pham Minh Chinh has suggested Ericsson's cooperation with Vietnam should focus on piloting innovation initiatives, 6G research, and building a database for AI in the country.
Economy - Sat, June 14, 2025 | 3:59 pm GMT+7
Swedish giants H&M, Syre to scale up operations in Vietnam
H&M, a globally renowned fashion brand from Sweden, plans to expand its network of stores in Vietnam to over 20 in the time to come, said CFO Adam Karlsson.
Industries - Sat, June 14, 2025 | 2:16 pm GMT+7
Leading industrial park developer Becamex to gain from Binh Duong province’s merger into HCMC: broker
Becamex IDC Corp, a leading urban and industrial park developer based in Binh Duong, is expected to benefit from the province’s merger into Ho Chi Minh City, with many new development opportunities, according to Vietcombank Securities (VCBS).
Companies - Sat, June 14, 2025 | 8:00 am GMT+7